pkn1 kinases (Carna Inc)
94
Structured Review
Carna Inc
pkn1 kinases
Pkn1 Kinases, supplied by Carna Inc, used in various techniques. Bioz Stars score: 94/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/01-144/PKN1/pmc10425724-39-14-19
Average 94 stars, based on 4 article reviews
Pkn1 Kinases, supplied by Carna Inc, used in various techniques. Bioz Stars score: 94/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/01-144/PKN1/pmc10425724-39-14-19
Average 94 stars, based on 4 article reviews
pkn1 kinases - by Bioz Stars,
2026-09
94/100 stars
Images
Related Articles
Titration:Article Title: BBT-176, a Novel Fourth-Generation Tyrosine Kinase Inhibitor for Osimertinib-Resistant EGFR Mutations in Non–Small Cell Lung Cancer Article Snippet: The Fluorescence:Article Title: BBT-176, a Novel Fourth-Generation Tyrosine Kinase Inhibitor for Osimertinib-Resistant EGFR Mutations in Non–Small Cell Lung Cancer Article Snippet: The Concentration Assay:Article Title: BBT-176, a Novel Fourth-Generation Tyrosine Kinase Inhibitor for Osimertinib-Resistant EGFR Mutations in Non–Small Cell Lung Cancer Article Snippet: The Binding Assay:Article Title: BBT-176, a Novel Fourth-Generation Tyrosine Kinase Inhibitor for Osimertinib-Resistant EGFR Mutations in Non–Small Cell Lung Cancer Article Snippet: The Inhibition:Article Title: BBT-176, a Novel Fourth-Generation Tyrosine Kinase Inhibitor for Osimertinib-Resistant EGFR Mutations in Non–Small Cell Lung Cancer Article Snippet: The Activity Assay:Article Title: BBT-176, a Novel Fourth-Generation Tyrosine Kinase Inhibitor for Osimertinib-Resistant EGFR Mutations in Non–Small Cell Lung Cancer Article Snippet: The Phospho-proteomics:Article Title: BBT-176, a Novel Fourth-Generation Tyrosine Kinase Inhibitor for Osimertinib-Resistant EGFR Mutations in Non–Small Cell Lung Cancer Article Snippet: The |